-
1
-
-
0026839350
-
Hodgkin's disease derived cell lines: a review
-
Drexler H.G., and Minowada J. Hodgkin's disease derived cell lines: a review. Hum Cell 5 (1992) 42-53
-
(1992)
Hum Cell
, vol.5
, pp. 42-53
-
-
Drexler, H.G.1
Minowada, J.2
-
2
-
-
0036893768
-
Hodgkin and Reed-Sternberg cell-associated autoantigen CLIP-170/restin is a marker for dendritic cells and is involved in the trafficking of macropinosomes to the cytoskeleton, supporting a function-based concept of Hodgkin and Reed-Sternberg cells
-
Sahin U., Neumann F., Tureci O., Schmits R., Perez F., and Pfreundschuh M. Hodgkin and Reed-Sternberg cell-associated autoantigen CLIP-170/restin is a marker for dendritic cells and is involved in the trafficking of macropinosomes to the cytoskeleton, supporting a function-based concept of Hodgkin and Reed-Sternberg cells. Blood 100 (2002) 4139-4145
-
(2002)
Blood
, vol.100
, pp. 4139-4145
-
-
Sahin, U.1
Neumann, F.2
Tureci, O.3
Schmits, R.4
Perez, F.5
Pfreundschuh, M.6
-
3
-
-
0037441887
-
Loss of the B-lineage-specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma
-
Schwering I., Brauninger A., Klein U., et al. Loss of the B-lineage-specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood 101 (2003) 1505-1512
-
(2003)
Blood
, vol.101
, pp. 1505-1512
-
-
Schwering, I.1
Brauninger, A.2
Klein, U.3
-
4
-
-
2942724673
-
The concept of the GPOH-HD 2003 therapy study for pediatric Hodgkin's disease: evolution in the tradition of the DAL/GPOH studies
-
Körholz D., Claviez A., Hasenclever D., et al. The concept of the GPOH-HD 2003 therapy study for pediatric Hodgkin's disease: evolution in the tradition of the DAL/GPOH studies. Klin Padiatr 216 (2004) 150-156
-
(2004)
Klin Padiatr
, vol.216
, pp. 150-156
-
-
Körholz, D.1
Claviez, A.2
Hasenclever, D.3
-
5
-
-
33745860068
-
Working Group. Hodgkin disease survival in Europe and the US: prognostic significance of morphologic groups
-
Allemani C., Sant M., De Angelis R., Marcos-Gragera R., Coebergh J.W., and Eurocare. Working Group. Hodgkin disease survival in Europe and the US: prognostic significance of morphologic groups. Cancer 107 (2006) 352-360
-
(2006)
Cancer
, vol.107
, pp. 352-360
-
-
Allemani, C.1
Sant, M.2
De Angelis, R.3
Marcos-Gragera, R.4
Coebergh, J.W.5
Eurocare6
-
6
-
-
33749262442
-
Very high levels of soluble CD30 recognize the patients with classical Hodgkin's lymphoma retaining a very poor prognosis
-
Visco C., Nadali G., Vassilakopoulos T.P., et al. Very high levels of soluble CD30 recognize the patients with classical Hodgkin's lymphoma retaining a very poor prognosis. Eur J Haematol 77 (2006) 387-394
-
(2006)
Eur J Haematol
, vol.77
, pp. 387-394
-
-
Visco, C.1
Nadali, G.2
Vassilakopoulos, T.P.3
-
7
-
-
0038011922
-
Prognostic factors for children with Hodgkin's disease treated with combined-modality therapy
-
Smith R.S., Chen Q., Hudson M.M., et al. Prognostic factors for children with Hodgkin's disease treated with combined-modality therapy. J Clin Oncol 21 (2003) 2026-2033
-
(2003)
J Clin Oncol
, vol.21
, pp. 2026-2033
-
-
Smith, R.S.1
Chen, Q.2
Hudson, M.M.3
-
8
-
-
33645998113
-
The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin's disease
-
Gallamini A., Rigacci L., Merli F., et al. The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin's disease. Haematologica 91 (2006) 475-481
-
(2006)
Haematologica
, vol.91
, pp. 475-481
-
-
Gallamini, A.1
Rigacci, L.2
Merli, F.3
-
9
-
-
33750598940
-
Prognostic significance of T-Cell or cytotoxic molecules phenotype in classical Hodgkin's lymphoma: a clinicopathologic Study
-
Asano N., Oshiro A., Matsuo K., et al. Prognostic significance of T-Cell or cytotoxic molecules phenotype in classical Hodgkin's lymphoma: a clinicopathologic Study. J Clin Oncol 24 (2006) 4626-4633
-
(2006)
J Clin Oncol
, vol.24
, pp. 4626-4633
-
-
Asano, N.1
Oshiro, A.2
Matsuo, K.3
-
10
-
-
33646245179
-
MAL is expressed in a subset of Hodgkin lymphoma and identifies a population of patients with poor prognosis
-
Hsi E.D., Sup S.J., Alemany C., et al. MAL is expressed in a subset of Hodgkin lymphoma and identifies a population of patients with poor prognosis. Am J Clin Pathol 125 (2006) 776-782
-
(2006)
Am J Clin Pathol
, vol.125
, pp. 776-782
-
-
Hsi, E.D.1
Sup, S.J.2
Alemany, C.3
-
11
-
-
33745938078
-
Tumor microenvironment and mitotic checkpoint are key factors in the outcome of classic Hodgkin lymphoma
-
Sanchez-Aguilera A., Montalban C., de la Cueva P., et al. Tumor microenvironment and mitotic checkpoint are key factors in the outcome of classic Hodgkin lymphoma. Blood 108 (2006) 662-668
-
(2006)
Blood
, vol.108
, pp. 662-668
-
-
Sanchez-Aguilera, A.1
Montalban, C.2
de la Cueva, P.3
-
12
-
-
8544237013
-
DNA microarrays reveal relationship of Ewing family tumors to both endothelial and fetal neural crest-derived cells and define novel targets
-
Staege M.S., Hutter C., Neumann I., et al. DNA microarrays reveal relationship of Ewing family tumors to both endothelial and fetal neural crest-derived cells and define novel targets. Cancer Res 64 (2004) 8213-8221
-
(2004)
Cancer Res
, vol.64
, pp. 8213-8221
-
-
Staege, M.S.1
Hutter, C.2
Neumann, I.3
-
13
-
-
15844383634
-
Peripheral blood mononuclear cells of a patient with advanced Hodgkin's lymphoma give rise to permanently growing Hodgkin-Reed Sternberg cells
-
Wolf J., Kapp U., Bohlen H., et al. Peripheral blood mononuclear cells of a patient with advanced Hodgkin's lymphoma give rise to permanently growing Hodgkin-Reed Sternberg cells. Blood 87 (1996) 3418-3428
-
(1996)
Blood
, vol.87
, pp. 3418-3428
-
-
Wolf, J.1
Kapp, U.2
Bohlen, H.3
-
14
-
-
0019521012
-
Hodgkin's disease: establishment and characterization of four in vitro cell lines
-
Diehl V., Kirchner H.H., Schaadt M., et al. Hodgkin's disease: establishment and characterization of four in vitro cell lines. J Cancer Res Clin Oncol 101 (1981) 111-124
-
(1981)
J Cancer Res Clin Oncol
, vol.101
, pp. 111-124
-
-
Diehl, V.1
Kirchner, H.H.2
Schaadt, M.3
-
15
-
-
0022504817
-
Cytochemical, immunologic, chromosomal, and molecular genetic analysis of a novel cell line derived from Hodgkin's disease
-
Kamesaki H., Fukuhara S., Tatsumi E., et al. Cytochemical, immunologic, chromosomal, and molecular genetic analysis of a novel cell line derived from Hodgkin's disease. Blood 68 (1986) 285-292
-
(1986)
Blood
, vol.68
, pp. 285-292
-
-
Kamesaki, H.1
Fukuhara, S.2
Tatsumi, E.3
-
16
-
-
0022633035
-
Hodgkin's disease derived cell lines HDLM-2 and L-428: comparison of morphology, immunological and isoenzyme profiles
-
Drexler H.G., Gaedicke G., Lok M.S., Diehl V., and Minowada J. Hodgkin's disease derived cell lines HDLM-2 and L-428: comparison of morphology, immunological and isoenzyme profiles. Leuk Res 10 (1986) 487-500
-
(1986)
Leuk Res
, vol.10
, pp. 487-500
-
-
Drexler, H.G.1
Gaedicke, G.2
Lok, M.S.3
Diehl, V.4
Minowada, J.5
-
17
-
-
2942559140
-
Functional and molecular characterization of interleukin-2 transgenic Ewing tumor cells for in vivo immunotherapy
-
Staege M.S., Hansen G., Baersch G., and Burdach S. Functional and molecular characterization of interleukin-2 transgenic Ewing tumor cells for in vivo immunotherapy. Pediatr Blood Cancer 43 (2004) 23-34
-
(2004)
Pediatr Blood Cancer
, vol.43
, pp. 23-34
-
-
Staege, M.S.1
Hansen, G.2
Baersch, G.3
Burdach, S.4
-
18
-
-
27344435774
-
Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles
-
Subramanian A., Tamayo P., Mootha V.K., et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102 (2005) 15545-15550
-
(2005)
Proc Natl Acad Sci U S A
, vol.102
, pp. 15545-15550
-
-
Subramanian, A.1
Tamayo, P.2
Mootha, V.K.3
-
19
-
-
21444445235
-
Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues
-
Ge X., Yamamoto S., Tsutsumi S., et al. Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 86 (2005) 127-141
-
(2005)
Genomics
, vol.86
, pp. 127-141
-
-
Ge, X.1
Yamamoto, S.2
Tsutsumi, S.3
-
20
-
-
8144224903
-
Proliferation profile of classical Hodgkin's lymphomas. Increased expression of the protein cyclin D2 in Hodgkin's and Reed-Sternberg cells
-
Bai M., Tsanou E., Agnantis N.J., et al. Proliferation profile of classical Hodgkin's lymphomas. Increased expression of the protein cyclin D2 in Hodgkin's and Reed-Sternberg cells. Mod Pathol 17 (2004) 1338-1345
-
(2004)
Mod Pathol
, vol.17
, pp. 1338-1345
-
-
Bai, M.1
Tsanou, E.2
Agnantis, N.J.3
-
21
-
-
0344771027
-
High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease: the German-Austrian multicenter trial DAL-HD-90. The German-Austrian Pediatric Hodgkin's Disease Study Group
-
Schellong G., Potter R., Bramswig J., et al. High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease: the German-Austrian multicenter trial DAL-HD-90. The German-Austrian Pediatric Hodgkin's Disease Study Group. J Clin Oncol 17 (1999) 3736-3744
-
(1999)
J Clin Oncol
, vol.17
, pp. 3736-3744
-
-
Schellong, G.1
Potter, R.2
Bramswig, J.3
-
22
-
-
0037097044
-
Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial
-
Schmitz N., Pfistner B., Sextro M., et al. Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial. Lancet 359 (2002) 2065-2071
-
(2002)
Lancet
, vol.359
, pp. 2065-2071
-
-
Schmitz, N.1
Pfistner, B.2
Sextro, M.3
-
23
-
-
0033841146
-
Double high-dose therapy for Hodgkin's disease with dose-intensive cyclophosphamide, etoposide, and cisplatin (DICEP) prior to high-dose melphalan and autologous stem cell transplantation
-
Stewart D.A., Guo D., Glück S., et al. Double high-dose therapy for Hodgkin's disease with dose-intensive cyclophosphamide, etoposide, and cisplatin (DICEP) prior to high-dose melphalan and autologous stem cell transplantation. Bone Marrow Transplant 26 (2000) 383-388
-
(2000)
Bone Marrow Transplant
, vol.26
, pp. 383-388
-
-
Stewart, D.A.1
Guo, D.2
Glück, S.3
-
24
-
-
19944426729
-
Cologne high-dose sequential chemotherapy in relapsed and refractory Hodgkin lymphoma: results of a large multicenter study of the German Hodgkin Lymphoma Study Group (GHSG)
-
Josting A., Rudolph C., Mapara M., et al. Cologne high-dose sequential chemotherapy in relapsed and refractory Hodgkin lymphoma: results of a large multicenter study of the German Hodgkin Lymphoma Study Group (GHSG). Ann Oncol 16 (2005) 116-123
-
(2005)
Ann Oncol
, vol.16
, pp. 116-123
-
-
Josting, A.1
Rudolph, C.2
Mapara, M.3
-
25
-
-
0032530947
-
IL-13 suppresses TNF-induced activation of nuclear factor-kappa B, activation protein-1, and apoptosis
-
Manna S.K., and Aggarwal B.B. IL-13 suppresses TNF-induced activation of nuclear factor-kappa B, activation protein-1, and apoptosis. J Immunol 161 (1998) 2863-2872
-
(1998)
J Immunol
, vol.161
, pp. 2863-2872
-
-
Manna, S.K.1
Aggarwal, B.B.2
-
26
-
-
0035992266
-
The role of interleukin 13 in classical Hodgkin lymphoma
-
1203-1120
-
Skinnider B.F., Kapp U., and Mak T.W. The role of interleukin 13 in classical Hodgkin lymphoma. Leuk Lymphoma 43 (2002) 1203-1120
-
(2002)
Leuk Lymphoma
, vol.43
-
-
Skinnider, B.F.1
Kapp, U.2
Mak, T.W.3
-
27
-
-
0030960075
-
Interleukin-13 in combination with CD40 ligand potently inhibits apoptosis in human B lymphocytes: upregulation of Bcl-xL and Mcl-1
-
Lomo J., Blomhoff H.K., Jacobsen S.E., Krajewski S., Reed J.C., and Smeland E.B. Interleukin-13 in combination with CD40 ligand potently inhibits apoptosis in human B lymphocytes: upregulation of Bcl-xL and Mcl-1. Blood 89 (1997) 4415-4424
-
(1997)
Blood
, vol.89
, pp. 4415-4424
-
-
Lomo, J.1
Blomhoff, H.K.2
Jacobsen, S.E.3
Krajewski, S.4
Reed, J.C.5
Smeland, E.B.6
-
28
-
-
0035135322
-
Activated Notch1 can transiently substitute for EBNA2 in the maintenance of proliferation of LMP1-expressing immortalized B cells
-
Hofelmayr H., Strobl L.J., Marschall G., Bornkamm G.W., and Zimber-Strobl U. Activated Notch1 can transiently substitute for EBNA2 in the maintenance of proliferation of LMP1-expressing immortalized B cells. J Virol 75 (2001) 2033-2040
-
(2001)
J Virol
, vol.75
, pp. 2033-2040
-
-
Hofelmayr, H.1
Strobl, L.J.2
Marschall, G.3
Bornkamm, G.W.4
Zimber-Strobl, U.5
-
29
-
-
0032479924
-
Differential effect of B lymphocyte-induced maturation protein (Blimp-1) expression on cell fate during B cell development
-
515-255
-
Messika E.J., Lu P.S., Sung Y.J., et al. Differential effect of B lymphocyte-induced maturation protein (Blimp-1) expression on cell fate during B cell development. J Exp Med 188 (1998) 515-255
-
(1998)
J Exp Med
, vol.188
-
-
Messika, E.J.1
Lu, P.S.2
Sung, Y.J.3
-
30
-
-
33745381226
-
BLIMP-1 is a target of cellular stress and downstream of the unfolded protein response
-
Doody G.M., Stephenson S., and Tooze R.M. BLIMP-1 is a target of cellular stress and downstream of the unfolded protein response. Eur J Immunol 36 (2006) 1572-1582
-
(2006)
Eur J Immunol
, vol.36
, pp. 1572-1582
-
-
Doody, G.M.1
Stephenson, S.2
Tooze, R.M.3
-
31
-
-
0036143638
-
Expression of CD40 ligand (CD154) in B and T lymphocytes of Hodgkin disease: potential therapeutic significance
-
Clodi K., Asgari Z., Younes M., et al. Expression of CD40 ligand (CD154) in B and T lymphocytes of Hodgkin disease: potential therapeutic significance. Cancer 94 (2002) 1-5
-
(2002)
Cancer
, vol.94
, pp. 1-5
-
-
Clodi, K.1
Asgari, Z.2
Younes, M.3
-
32
-
-
0035085332
-
CD40 ligand-an anti-apoptotic molecule in Hodgkin's disease
-
Metkar S.S., Manna P.P., Anand M., Naresh K.N., Advani S.H., and Nadkarni J.J. CD40 ligand-an anti-apoptotic molecule in Hodgkin's disease. Cancer Biother Radiopharm 16 (2001) 85-92
-
(2001)
Cancer Biother Radiopharm
, vol.16
, pp. 85-92
-
-
Metkar, S.S.1
Manna, P.P.2
Anand, M.3
Naresh, K.N.4
Advani, S.H.5
Nadkarni, J.J.6
-
33
-
-
16344370583
-
B-cell differentiation, apoptosis and proliferation in diffuse large B-cell lymphomas
-
Bai M., Skyrlas A., Agnantis N.J., et al. B-cell differentiation, apoptosis and proliferation in diffuse large B-cell lymphomas. Anticancer Res 25 (2005) 347-362
-
(2005)
Anticancer Res
, vol.25
, pp. 347-362
-
-
Bai, M.1
Skyrlas, A.2
Agnantis, N.J.3
-
34
-
-
15944381195
-
Distinct IL-4-induced gene expression, proliferation, and intracellular signaling in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas
-
Lu X., Nechushtan H., Ding F., et al. Distinct IL-4-induced gene expression, proliferation, and intracellular signaling in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas. Blood 105 (2005) 2924-2932
-
(2005)
Blood
, vol.105
, pp. 2924-2932
-
-
Lu, X.1
Nechushtan, H.2
Ding, F.3
-
35
-
-
34547135697
-
MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma
-
Lawrie C.H., Soneji S., Marafioti T., et al. MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma. Int J Cancer 121 (2007) 1156-1161
-
(2007)
Int J Cancer
, vol.121
, pp. 1156-1161
-
-
Lawrie, C.H.1
Soneji, S.2
Marafioti, T.3
-
36
-
-
32144456222
-
Molecular alterations of cells resistant to platinum drugs: role of PKCalpha
-
Righetti S.C., Perego P., Carenini N., et al. Molecular alterations of cells resistant to platinum drugs: role of PKCalpha. Biochim Biophys Acta 1763 (2006) 93-100
-
(2006)
Biochim Biophys Acta
, vol.1763
, pp. 93-100
-
-
Righetti, S.C.1
Perego, P.2
Carenini, N.3
-
37
-
-
0027528956
-
Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptors
-
Birkenbach M., Josefsen K., Yalamanchili R., Lenoir G., and Kieff E. Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptors. J Virol 67 (1993) 2209-2220
-
(1993)
J Virol
, vol.67
, pp. 2209-2220
-
-
Birkenbach, M.1
Josefsen, K.2
Yalamanchili, R.3
Lenoir, G.4
Kieff, E.5
-
38
-
-
0036605042
-
Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to Apo2L/TRAIL-induced apoptosis
-
Evdokiou A., Bouralexis S., Atkins G.J., et al. Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to Apo2L/TRAIL-induced apoptosis. Int J Cancer 99 (2002) 491-504
-
(2002)
Int J Cancer
, vol.99
, pp. 491-504
-
-
Evdokiou, A.1
Bouralexis, S.2
Atkins, G.J.3
-
39
-
-
0042845974
-
Progressive resistance of BTK-143 osteosarcoma cells to Apo2L/TRAIL-induced apoptosis is mediated by acquisition of DcR2/TRAIL-R4 expression: resensitisation with chemotherapy
-
Bouralexis S., Findlay D.M., Atkins G.J., et al. Progressive resistance of BTK-143 osteosarcoma cells to Apo2L/TRAIL-induced apoptosis is mediated by acquisition of DcR2/TRAIL-R4 expression: resensitisation with chemotherapy. Br J Cancer 89 (2003) 206-214
-
(2003)
Br J Cancer
, vol.89
, pp. 206-214
-
-
Bouralexis, S.1
Findlay, D.M.2
Atkins, G.J.3
-
40
-
-
0030880815
-
X chromosome inactivation is mediated by Xist RNA stabilization
-
Panning B., Dausman J., and Jaenisch R. X chromosome inactivation is mediated by Xist RNA stabilization. Cell 90 (1997) 907-916
-
(1997)
Cell
, vol.90
, pp. 907-916
-
-
Panning, B.1
Dausman, J.2
Jaenisch, R.3
-
41
-
-
0036691881
-
Relationship of XIST expression and responses of ovarian cancer to chemotherapy
-
Huang K.C., Rao P.H., Lau C.C., et al. Relationship of XIST expression and responses of ovarian cancer to chemotherapy. Mol Cancer Ther 1 (2002) 769-776
-
(2002)
Mol Cancer Ther
, vol.1
, pp. 769-776
-
-
Huang, K.C.1
Rao, P.H.2
Lau, C.C.3
-
42
-
-
0028212159
-
The human X-inactivation centre is not required for maintenance of X-chromosome inactivation
-
Brown C.J., and Willard H.F. The human X-inactivation centre is not required for maintenance of X-chromosome inactivation. Nature 368 (1994) 154-156
-
(1994)
Nature
, vol.368
, pp. 154-156
-
-
Brown, C.J.1
Willard, H.F.2
-
44
-
-
0037376848
-
The roles of supernumerical X chromosomes and XIST expression in testicular germ cell tumors
-
Kawakami T., Okamoto K., Sugihara H., et al. The roles of supernumerical X chromosomes and XIST expression in testicular germ cell tumors. J Urol 169 (2003) 1546-1552
-
(2003)
J Urol
, vol.169
, pp. 1546-1552
-
-
Kawakami, T.1
Okamoto, K.2
Sugihara, H.3
-
45
-
-
0030840990
-
X inactivation in human testicular tumors. XIST expression and androgen receptor methylation status
-
Looijenga L.H., Gillis A.J., van Gurp R.J., Verkerk A.J., and Oosterhuis J.W. X inactivation in human testicular tumors. XIST expression and androgen receptor methylation status. Am J Pathol 151 (1997) 581-590
-
(1997)
Am J Pathol
, vol.151
, pp. 581-590
-
-
Looijenga, L.H.1
Gillis, A.J.2
van Gurp, R.J.3
Verkerk, A.J.4
Oosterhuis, J.W.5
-
46
-
-
0031570315
-
Chromosome mapping and expression of the human interleukin-13 receptor
-
Guo J., Apiou F., Mellerin M.-P., Lebeau B., Jacques Y., and Minvielle S. Chromosome mapping and expression of the human interleukin-13 receptor. Genomics 42 (1997) 141-145
-
(1997)
Genomics
, vol.42
, pp. 141-145
-
-
Guo, J.1
Apiou, F.2
Mellerin, M.-P.3
Lebeau, B.4
Jacques, Y.5
Minvielle, S.6
-
47
-
-
4444276547
-
In vitro drug sensitivity and apoptosis induction in newly diagnosed pediatric acute lymphoblastic leukemia: correlation with overall survival
-
Srinivas G., Kusumakumary P., Joseph T., and Pillai M.R. In vitro drug sensitivity and apoptosis induction in newly diagnosed pediatric acute lymphoblastic leukemia: correlation with overall survival. Pediatr Hematol Oncol 21 (2004) 465-473
-
(2004)
Pediatr Hematol Oncol
, vol.21
, pp. 465-473
-
-
Srinivas, G.1
Kusumakumary, P.2
Joseph, T.3
Pillai, M.R.4
-
48
-
-
0034264426
-
Spontaneous apoptosis of Reed-Sternberg and Hodgkin cells; clinical and pathological implications in patients with Hodgkin's disease
-
Smolewski P., Niewiadomska H., Los E., and Robak T. Spontaneous apoptosis of Reed-Sternberg and Hodgkin cells; clinical and pathological implications in patients with Hodgkin's disease. Int J Oncol 17 (2000) 603-609
-
(2000)
Int J Oncol
, vol.17
, pp. 603-609
-
-
Smolewski, P.1
Niewiadomska, H.2
Los, E.3
Robak, T.4
-
49
-
-
36448955314
-
Prognostic significance of cell proliferation and apoptosis-regulating proteins in Epstein-Barr virus positive and negative pediatric Hodgkin lymphoma
-
Aktaş S., Kargi A., Olgun N., Diniz G., Erbay A., and Vergin C. Prognostic significance of cell proliferation and apoptosis-regulating proteins in Epstein-Barr virus positive and negative pediatric Hodgkin lymphoma. Lymphat Res Biol 5 (2007) 175-182
-
(2007)
Lymphat Res Biol
, vol.5
, pp. 175-182
-
-
Aktaş, S.1
Kargi, A.2
Olgun, N.3
Diniz, G.4
Erbay, A.5
Vergin, C.6
-
50
-
-
0036258312
-
The disappearance of prognostic factors in Hodgkin's disease
-
Hasenclever D. The disappearance of prognostic factors in Hodgkin's disease. Ann Oncol 13 suppl 1 (2002) 75-78
-
(2002)
Ann Oncol
, vol.13
, Issue.SUPPL. 1
, pp. 75-78
-
-
Hasenclever, D.1
-
51
-
-
19944426160
-
Cytotoxic T lymphocyte therapy for Epstein-Barr virus+ Hodgkin's disease
-
Bollard C.M., Aguilar L., Straathof K.C., et al. Cytotoxic T lymphocyte therapy for Epstein-Barr virus+ Hodgkin's disease. J Exp Med 200 (2004) 1623-1633
-
(2004)
J Exp Med
, vol.200
, pp. 1623-1633
-
-
Bollard, C.M.1
Aguilar, L.2
Straathof, K.C.3
-
52
-
-
20444410110
-
Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation
-
Peggs K.S., Hunter A., Chopra R., et al. Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation. Lancet 365 (2005) 1934-1941
-
(2005)
Lancet
, vol.365
, pp. 1934-1941
-
-
Peggs, K.S.1
Hunter, A.2
Chopra, R.3
-
53
-
-
28244446162
-
Tumor-infiltrating cells as a prognostic factor in Hodgkin's lymphoma: a quantitative tissue microarray study in a large retrospective cohort of 267 patients
-
Alvaro-Naranjo T., Lejeune M., Salvado-Usach M.T., et al. Tumor-infiltrating cells as a prognostic factor in Hodgkin's lymphoma: a quantitative tissue microarray study in a large retrospective cohort of 267 patients. Leuk Lymphoma 46 (2005) 1581-1591
-
(2005)
Leuk Lymphoma
, vol.46
, pp. 1581-1591
-
-
Alvaro-Naranjo, T.1
Lejeune, M.2
Salvado-Usach, M.T.3
-
54
-
-
1442283424
-
Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma
-
Marshall N.A., Christie L.E., Munro L.R., et al. Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma. Blood 103 (2004) 1755-1762
-
(2004)
Blood
, vol.103
, pp. 1755-1762
-
-
Marshall, N.A.1
Christie, L.E.2
Munro, L.R.3
-
55
-
-
34548395936
-
Hodgkin's Reed-Sternberg cell line (KM-H2) promotes a bidirectional differentiation of CD4+CD25+Foxp3+ T cells and CD4+ cytotoxic T lymphocytes from CD4+ naive T cells
-
[Epub ahead of print]
-
Tanijiri T., Shimizu T., Uehira K., et al. Hodgkin's Reed-Sternberg cell line (KM-H2) promotes a bidirectional differentiation of CD4+CD25+Foxp3+ T cells and CD4+ cytotoxic T lymphocytes from CD4+ naive T cells. J Leukoc Biol (2007 Jun 1) [Epub ahead of print]
-
(2007)
J Leukoc Biol
-
-
Tanijiri, T.1
Shimizu, T.2
Uehira, K.3
-
56
-
-
20044367117
-
Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells
-
1467-1467
-
Alvaro T., Lejeune M., Salvado M.T., et al. Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells. Clin Cancer Res 11 (2005) 1467-1467
-
(2005)
Clin Cancer Res
, vol.11
-
-
Alvaro, T.1
Lejeune, M.2
Salvado, M.T.3
-
57
-
-
0037007063
-
MYC overexpression imposes a nonimmunogenic phenotype on Epstein-Barr virus-infected B cells
-
Staege M.S., Lee S.P., Frisan T., et al. MYC overexpression imposes a nonimmunogenic phenotype on Epstein-Barr virus-infected B cells. Proc Natl Acad Sci U S A 99 (2002) 4550-4555
-
(2002)
Proc Natl Acad Sci U S A
, vol.99
, pp. 4550-4555
-
-
Staege, M.S.1
Lee, S.P.2
Frisan, T.3
-
58
-
-
33744789369
-
Detection and functional analysis of CD8+ T cells specific for PRAME: a target for T-cell therapy
-
Griffioen M., Kessler J.H., Borghi M., et al. Detection and functional analysis of CD8+ T cells specific for PRAME: a target for T-cell therapy. Clin Cancer Res 12 (2006) 3130-3136
-
(2006)
Clin Cancer Res
, vol.12
, pp. 3130-3136
-
-
Griffioen, M.1
Kessler, J.H.2
Borghi, M.3
-
59
-
-
3042770820
-
The tumor-associated antigen PRAME is universally expressed in high-stage neuroblastoma and associated with poor outcome
-
Oberthuer A., Hero B., Spitz R., Berthold F., and Fischer M. The tumor-associated antigen PRAME is universally expressed in high-stage neuroblastoma and associated with poor outcome. Clin Cancer Res 10 (2004) 4307-4313
-
(2004)
Clin Cancer Res
, vol.10
, pp. 4307-4313
-
-
Oberthuer, A.1
Hero, B.2
Spitz, R.3
Berthold, F.4
Fischer, M.5
-
60
-
-
33750084187
-
Expression analysis of stage III serous ovarian adenocarcinoma distinguishes a sub-group of survivors
-
Partheen K., Levan K., Osterberg L., and Horvath G. Expression analysis of stage III serous ovarian adenocarcinoma distinguishes a sub-group of survivors. Eur J Cancer 42 (2006) 2846-2854
-
(2006)
Eur J Cancer
, vol.42
, pp. 2846-2854
-
-
Partheen, K.1
Levan, K.2
Osterberg, L.3
Horvath, G.4
-
61
-
-
33749843270
-
Tumor mRNA-transfected dendritic cells stimulate the generation of CTL that recognize neuroblastoma-associated antigens and kill tumor cells: immunotherapeutic implications
-
Morandi F., Chiesa S., Bocca P., et al. Tumor mRNA-transfected dendritic cells stimulate the generation of CTL that recognize neuroblastoma-associated antigens and kill tumor cells: immunotherapeutic implications. Neoplasia 8 (2006) 833-842
-
(2006)
Neoplasia
, vol.8
, pp. 833-842
-
-
Morandi, F.1
Chiesa, S.2
Bocca, P.3
-
62
-
-
33744469340
-
Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma
-
Willenbrock K., Küppers R., Renné C., et al. Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma. Haematologica 91 (2006) 596-604
-
(2006)
Haematologica
, vol.91
, pp. 596-604
-
-
Willenbrock, K.1
Küppers, R.2
Renné, C.3
-
63
-
-
34447573999
-
Phase I/II study of an anti-CD30 monoclonal antibody (MDX-060) in Hodgkin's lymphoma and anaplastic large-cell lymphoma
-
Ansell S.M., Horwitz S.M., Engert A., et al. Phase I/II study of an anti-CD30 monoclonal antibody (MDX-060) in Hodgkin's lymphoma and anaplastic large-cell lymphoma. J Clin Oncol 25 (2007) 2764-2769
-
(2007)
J Clin Oncol
, vol.25
, pp. 2764-2769
-
-
Ansell, S.M.1
Horwitz, S.M.2
Engert, A.3
|